Chudenko (1941) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
9 Mar, 2026Executive summary
Net sales for the quarter ended June 30, 2025, were ¥44,422 million, down 2.7% year-over-year.
Operating profit rose 49.6% year-over-year to ¥4,271 million.
Ordinary profit increased 38.4% to ¥4,987 million, and profit attributable to owners of parent grew 51.8% to ¥3,345 million.
Comprehensive income for the quarter was ¥2,903 million, up 8.8% year-over-year.
Financial highlights
Gross profit increased to ¥8,606 million from ¥6,877 million year-over-year.
Basic earnings per share for the quarter was ¥61.80, up from ¥40.65 a year earlier.
Total assets as of June 30, 2025, were ¥287,786 million, with net assets at ¥229,224 million.
Capital adequacy ratio improved to 78.6% from 77.1% at the previous fiscal year-end.
Outlook and guidance
Full-year net sales forecast is ¥230,000 million, up 3.7% year-over-year.
Operating profit for the full year is projected at ¥22,000 million, up 1.4% year-over-year.
Ordinary profit forecast is ¥23,800 million, up 1.6% year-over-year; profit attributable to owners of parent is expected to decline 20.6% to ¥15,800 million.
Full-year basic earnings per share forecast is ¥291.77.
Annual dividend forecast is ¥130.00 per share, up from ¥120.00 in the previous year.
Latest events from Chudenko
- Record profit growth and raised full-year outlook, with higher interim dividend declared.1941
Q2 20259 Mar 2026 - Record sales and profit growth, with higher dividends and lower net profit forecast.1941
Q4 20259 Mar 2026 - Record interim profits, higher dividends, and an upward outlook despite lower sales.1941
Q2 20269 Mar 2026 - Strong sales growth and profit recovery, with higher dividends forecast for the year.1941
Q1 20259 Mar 2026 - Strong year-over-year profit and sales growth with an optimistic full-year outlook.1941
Q3 20259 Mar 2026 - Operating profit rose 18.7% despite a 2.5% sales decline; net profit fell 18.2% year-over-year.1941
Q3 20269 Mar 2026